WO1997005468A3 - A confirmatory serodiagnostic assay for infectious diseases - Google Patents

A confirmatory serodiagnostic assay for infectious diseases Download PDF

Info

Publication number
WO1997005468A3
WO1997005468A3 PCT/BR1996/000032 BR9600032W WO9705468A3 WO 1997005468 A3 WO1997005468 A3 WO 1997005468A3 BR 9600032 W BR9600032 W BR 9600032W WO 9705468 A3 WO9705468 A3 WO 9705468A3
Authority
WO
WIPO (PCT)
Prior art keywords
confirmatory
infectious diseases
antigen
strain
derived
Prior art date
Application number
PCT/BR1996/000032
Other languages
French (fr)
Other versions
WO1997005468A2 (en
Inventor
Pereira Rodolfo Mendes
Original Assignee
Pereira Rodolfo Mendes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pereira Rodolfo Mendes filed Critical Pereira Rodolfo Mendes
Priority to AU66518/96A priority Critical patent/AU6651896A/en
Publication of WO1997005468A2 publication Critical patent/WO1997005468A2/en
Publication of WO1997005468A3 publication Critical patent/WO1997005468A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Invention Patent of a confirmatory serodiagnostic assay for infectious diseases. The present invention refers to an antigen to be applied to diagnostic techniques and vaccines. The antigen, derived from Y strain or any other strain T. cruzi of epimastigote, or trypomastigote or amastigote forms, or from any other microorganism, is preserved in formol, fractioned in polyacrylamide gel (SDS-PAGE) and applied to a solid support. The diagnostic technique, derived from the application of same, is presented as confirmatory for the diagnosis of the Chagas' disease and of other human and animal infectious and/or parasitic diseases.
PCT/BR1996/000032 1995-07-25 1996-07-25 A confirmatory serodiagnostic assay for infectious diseases WO1997005468A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU66518/96A AU6651896A (en) 1995-07-25 1996-07-25 A confirmatory serodiagnostic assay for infectious diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI9503451-0 1995-07-25
BR9503451A BR9503451A (en) 1995-07-26 1995-07-26 Process of preparation of an antigen derived from a microorganism that causes infectious and / or parasitic disease Process of preparation of an antigen from T cruzi antigen derived from a microorganism that causes infectious disease and / or parasitic antigen derived from T cruzi that causes Chagas disease composition the base of an antigen derived from microorganism that causes infectious and / or parasitic disease composition the base of antigen from T cruzi use of the antigen derived from microorganism that causes infectious and / or parasitic disease in serological tests and vaccines use of antigen derived from T cruzi cause of chagas disease in serological tests and vaccines process for detecting antibodies against microorganism antigen causing infectious and / or parasitic disease and confirmatory serodiagnosis kit for infectious and / or parasitic disease

Publications (2)

Publication Number Publication Date
WO1997005468A2 WO1997005468A2 (en) 1997-02-13
WO1997005468A3 true WO1997005468A3 (en) 1997-05-22

Family

ID=4062056

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR1996/000032 WO1997005468A2 (en) 1995-07-25 1996-07-25 A confirmatory serodiagnostic assay for infectious diseases

Country Status (3)

Country Link
AU (1) AU6651896A (en)
BR (1) BR9503451A (en)
WO (1) WO1997005468A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9603267A (en) * 1996-08-02 1998-04-28 Univ Federal De Sao Paulo Process of preparation and use of trypanosoma cruzi antigens and assay for the diagnosis of Chagas disease
AU8604298A (en) * 1997-07-28 1999-02-16 Immunetics, Inc. Assay and device for identifying (trypanosoma cruzi) infection
US7749717B2 (en) 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911097A (en) * 1973-08-07 1975-10-07 Research Corp Antigenic preparation suitable for diagnosis of chronic chagas disease
EP0138101A1 (en) * 1983-09-30 1985-04-24 Rockefeller University Genetically engineered organisms expressing surface proteins of T. Cruzi
WO1992009895A1 (en) * 1990-11-28 1992-06-11 Fundação Oswaldo Cruz (Fiocruz) - Superintendência De Planejamento Composition and its preparation process using antigen conjugated to enzymatic activity for immunological diagnosis and chagas' disease immunological diagnosis kits, for individual and epidemiological application, based on that composition
WO1994001776A1 (en) * 1992-07-10 1994-01-20 Abbott Laboratories Assay for chagas' disease and reagents for its use
WO1994026899A1 (en) * 1993-05-13 1994-11-24 Institut Français De Recherche Scientifique Pour Le Developpement En Cooperation (Orstom) Method for the culture in vitro of differents stages of tissue parasites
WO1996029605A2 (en) * 1995-03-14 1996-09-26 Corixa Corporation Compounds and methods for the dectection of t. cruzi infection

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911097A (en) * 1973-08-07 1975-10-07 Research Corp Antigenic preparation suitable for diagnosis of chronic chagas disease
EP0138101A1 (en) * 1983-09-30 1985-04-24 Rockefeller University Genetically engineered organisms expressing surface proteins of T. Cruzi
WO1992009895A1 (en) * 1990-11-28 1992-06-11 Fundação Oswaldo Cruz (Fiocruz) - Superintendência De Planejamento Composition and its preparation process using antigen conjugated to enzymatic activity for immunological diagnosis and chagas' disease immunological diagnosis kits, for individual and epidemiological application, based on that composition
WO1994001776A1 (en) * 1992-07-10 1994-01-20 Abbott Laboratories Assay for chagas' disease and reagents for its use
WO1994026899A1 (en) * 1993-05-13 1994-11-24 Institut Français De Recherche Scientifique Pour Le Developpement En Cooperation (Orstom) Method for the culture in vitro of differents stages of tissue parasites
WO1996029605A2 (en) * 1995-03-14 1996-09-26 Corixa Corporation Compounds and methods for the dectection of t. cruzi infection

Also Published As

Publication number Publication date
AU6651896A (en) 1997-02-26
WO1997005468A2 (en) 1997-02-13
BR9503451A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
WO1999010375A3 (en) Vaccine against hpv
WO2003055513A3 (en) Bacillus subtilis spores to stimulate the immune responses
CA2207741A1 (en) Variants of human papilloma virus antigens
PT865297E (en) COMPOSITIONS OF VACCINES FOR INTRANASAL ADMINISTRATION UNDERSTANDING QUITOSAN AND ITS USES
EP2286834A3 (en) Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response
EP2368575A3 (en) Dry formulation for transcutaneous immunization
DK0859632T3 (en) Influenza Vaccine preparations
PT920322E (en) TREATMENT OF AUTONOMOUS DISEASES
DE69827792D1 (en) NON-IRRITATING COSMETIC AND PHARMACEUTICAL COMPOSITIONS
FI920132A0 (en) STABILA VACCINKOMPOSITIONER INNEHAOLLANDE INTERLEUKINER.
CY1107571T1 (en) NURSING GROWTH FACTOR AS Auxiliary Vaccine
AUPQ846900A0 (en) A vaccine
ES2078900T3 (en) COMPOSITION AND METHOD FOR THE PROTECTION AGAINST DISEASES CAUSED BY MICROORGANISMS.
ATE179333T1 (en) IMMUNOTHERAPEUTIC PREPARATION
ES2137310T3 (en) VACCINE AGAINST STREPTOCOCCUS SUIS INFECTION.
WO2001051008A3 (en) Selective activation of a th1 or th2 lymphocyte regulated immune response
WO1997005468A3 (en) A confirmatory serodiagnostic assay for infectious diseases
KR890013181A (en) Method for producing a recombinant protein derived from the surrounding spores gene of Plasmodium falciparum
MX9603124A (en) Mild newcastle disease virus vaccine.
AU3478393A (en) Vaccine containing acemannan as an adjuvant
WO1996032134A3 (en) Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
SU1538305A1 (en) Associated vaccine against peptospirosis and parvovirus infection of pigs
BR9814556A (en) Strains isolated from staphylococcus aureus and vaccines made from them
BR9305075A (en) Antigen to confer protective immunity against helminth infections in humans and animals, and vaccination process for application in the immunoprophylaxis of helminthological diseases of veterinary and medical interest
JP2003137805A5 (en) Serum lipid lowering agent and health food

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA